20 results
HIV HAART Medications - Classification by Names and Mechanism - Updated 01/2021
 - NRTIs
 - NNRTIs
HIV HAART Medications ... #AIDS #HAART #Medications ... #ART #Antiretroviral ... #Therapy #Pharmacology ... Classes #naming #nomenclature
Antiretroviral Medication Names and 3-Letter Abbreviations by Class

Paul E. Sax, MD

#Antiretroviral #Medication #Names #Classification #HAART #Classes
Classification #HAART ... #Classes #HIV # ... AIDS #Pharmacology ... #Nomenclature #
HIV Antiretroviral Medications Cheat Sheet

NRTIs
Integrase Inhibitors
NNRTIs
PIs
Fusion Inhibitors
CCR5 Antagonist
Post Attachment Inhibitor
Combination Pills
NRTI-Sparing
Resistance Mutations Summary - https://hivdb.stanford.edu/ 

By
HIV Antiretroviral ... @kbrownmd #HIV ... #AIDS #HAART #Medications ... Naming #Cheatsheet #Nomenclature ... Classification #Pharmacology
** See updated 01/2021 version here- https://www.grepmed.com/images/6497 **

HIV HAART Medications - Grouped by Brand Names and
images/6497 ** HIV ... HAART Medications ... #AIDS #HAART #Medications ... #ART #Antiretroviral ... #Therapy #Pharmacology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Women with in HIV-AIDS ... should be done at ... recommend a Pap test at ... opportunistic #infections #HIVAIDS ... #pharmacology
Pulmonary Infections in HIV-AIDS
Bacterial: 
 • No organism identified, Strep pneumoniae, H. influenzae, S.aureus, Streptococcus Grp
Infections in HIV-AIDS ... CD4 < 200: CMV, HSV ... CD4 > 200: Pulm embolism ... , Pulm edema, heart ... Pulmonary #Infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Infections in HIV-AIDS ... in response to ART ... to 5 mg/kg/day IV ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Trypanosomiasis) in HIV-AIDS ... still at risk of ... optimization of ART ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Candidiasis in HIV-AIDS ... Systemic antifungals are ... 400 mg) PO or IV ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
Disease (MCD) in HIV-AIDS ... and uncontrolled HIV ... specialist) + ART ... opportunistic #infections #HIVAIDS ... #pharmacology